Predictive Value of Positron Emission Tomography/Computed Tomography to Assess Early Treatment Response to Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade Without Chemotherapy for HER2-Positive Metastatic Breast Cancer: Are We Ready to Embrace This 'Early Metabolic Look' Strategy?

Jhaveri Komal; Ulaner Gary A.; Dickler Maura N.

首页> 外文期刊>Journal of Clinical Oncology >Predictive Value of Positron Emission Tomography/Computed Tomography to Assess Early Treatment Response to Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade Without Chemotherapy for HER2-Positive Metastatic Breast Cancer: Are We Ready to Embrace This 'Early Metabolic Look' Strategy?

【24h】

Predictive Value of Positron Emission Tomography/Computed Tomography to Assess Early Treatment Response to Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade Without Chemotherapy for HER2-Positive Metastatic Breast Cancer: Are We Ready to Embrace This 'Early Metabolic Look' Strategy?

机译：正电子发射断层扫描/计算机断层扫描对评估无HER2阳性转移性乳腺癌的未经化学疗法的双重人类表皮生长因子受体2（HER2）阻断的早期治疗反应的预测价值：我们准备好采用这种“早期代谢型”策略了吗？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Clinical Oncology》 |2015年第24期|共5页
作者
Jhaveri Komal; Ulaner Gary A.; Dickler Maura N.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Predictive Value of Positron Emission Tomography/Computed Tomography to Assess Early Treatment Response to Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade Without Chemotherapy for HER2-Positive Metastatic Breast Cancer: Are We Ready to Embrace This "Early Metabolic Look" Strategy? [J] . Jhaveri Komal, Ulaner Gary A., Dickler Maura N. Journal of Clinical Oncology . 2015,第24期

机译：正电子发射断层扫描/计算机断层扫描对评估无HER2阳性转移性乳腺癌的未经化学疗法的双重人类表皮生长因子受体2（HER2）阻断的早期治疗反应的预测价值：我们准备好采用这种“早期代谢型”策略了吗？
2. Treatment of Male Breast Cancer by Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade and Response Prediction Using Novel Optical Tomography Imaging: A Case Report [J] . Debasmita Saha, Susan Tannenbaum, Quing Zhu Cureus. . 2017,第7期

机译：双人类表皮生长因子受体2（HER2）阻断治疗男性乳腺癌和新型光学层析成像的反应预测：病例报告。
3. 18F-fluorodeoxyglucose positron emission tomography versus computed tomography in predicting histopathological response to epidermal growth factor receptor-tyrosine kinase inhibitor treatment in resectable non-small cell lung cancer [J] . VanGoolM.H., AukemaT.S., SchaakeE.E., Annals of surgical oncology . 2014,第9期

机译：18F-氟脱氧葡萄糖正电子发射断层扫描与计算机断层扫描在预测可切除非小细胞肺癌对表皮生长因子受体酪氨酸激酶抑制剂治疗的组织病理学反应中的作用
4. Indirect Costs Associated with Human Epidermal Growth Factor Receptor Positive (HER2+) Metastatic Breast Cancer [D] . Wright, Phoebe. 2020

机译：与人表皮生长因子受体阳性（HER2 +）转移性乳腺癌相关的间接成本
5. Treatment of Male Breast Cancer by Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade and Response Prediction Using Novel Optical Tomography Imaging: A Case Report [O] . Debasmita Saha, Susan Tannenbaum, Quing Zhu -1

机译：双人类表皮生长因子受体2（HER2）阻断治疗男性乳腺癌和新型光学层析成像的反应预测：病例报告。
6. Treatment of Male Breast Cancer by Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade and Response Prediction Using Novel Optical Tomography Imaging: A Case Report [O] . Debasmita Saha, Susan Tannenbaum, Quing Zhu 2017

机译：双重人表皮生长因子受体2（HER2）阻断和响应预测使用新型光学断层扫描成像治疗雄性乳腺癌：案例报告

Predictive Value of Positron Emission Tomography/Computed Tomography to Assess Early Treatment Response to Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade Without Chemotherapy for HER2-Positive Metastatic Breast Cancer: Are We Ready to Embrace This 'Early Metabolic Look' Strategy?

著录项

相似文献

相关主题

期刊订阅